| Financial Instruments |
7. Financial Instruments
Cash, Cash Equivalents, Restricted Cash and Marketable
Securities
The following tables show the Company’s cash,
cash equivalents, restricted cash, and marketable securities by significant investment category as of:
Schedule of Cash and Marketable Securities by Significant Investment Category
| | |
September 30, 2026 | |
| | |
Cost | | |
Unrealized
Gain/(Loss) | | |
Fair
Value | | |
Cash and
Cash
Equivalents | | |
Marketable
Securities | |
| Cash | |
$ | 3,220,000 | | |
$ | - | | |
$ | 3,220,000 | | |
$ | 3,220,000 | | |
$ | - | |
| Level 1 | |
| | | |
| | | |
| | | |
| | | |
| | |
| Money Market Funds | |
| 55,000 | | |
| - | | |
| 55,000 | | |
| 55,000 | | |
| - | |
| Marketable Securities | |
| 16,120,000 | | |
| (14,077,000 | ) | |
| 2,043,000 | | |
| - | | |
| 2,043,000 | |
| Total | |
$ | 19,395,000 | | |
$ | (14,077,000 | ) | |
$ | 5,318,000 | | |
$ | 3,275,000 | | |
$ | 2,043,000 | |
| | |
December 31, 2025 | |
| | |
Adjusted
Cost | | |
Unrealized
Gain/(Loss) | | |
Fair
Value | | |
Cash and
Cash
Equivalents | | |
Marketable
Securities | |
| Cash | |
$ | 4,981,000 | | |
$ | - | | |
$ | 4,981,000 | | |
$ | 4,981,000 | | |
$ | - | |
| Restricted Cash | |
| 100,000 | | |
| - | | |
| 100,000 | | |
| 100,000 | | |
| - | |
| Level 1 | |
| | | |
| | | |
| | | |
| | | |
| | |
| Money Market Funds | |
| 1,233,000 | | |
| - | | |
| 1,233,000 | | |
| 1,233,000 | | |
| - | |
| Marketable Securities | |
| 26,383,000 | | |
| (17,172,000 | ) | |
| 9,211,000 | | |
| - | | |
| 9,211,000 | |
| Total | |
$ | 32,697,000 | | |
$ | (17,172,000 | ) | |
$ | 15,525,000 | | |
$ | 6,314,000 | | |
$ | 9,211,000 | |
The Company typically invests
with the primary objective of minimizing the potential risk of principal loss. The Company’s investment policy generally requires
securities to be investment grade and limits the amount of credit exposure to any one issuer. Fair values were determined for each individual
security in the investment portfolio.
|